336 related articles for article (PubMed ID: 37253491)
1. Neoadjuvant camrelizumab plus chemotherapy for locally advanced cervical cancer (NACI Study): a study protocol of a prospective, single-arm, phase II trial.
Chen J; Han Y; Hu Y; Feng X; Meng X; Guo S; Sun C; Chen G; Li K
BMJ Open; 2023 May; 13(5):e067767. PubMed ID: 37253491
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant chemotherapy plus camrelizumab for locally advanced cervical cancer (NACI study): a multicentre, single-arm, phase 2 trial.
Li K; Chen J; Hu Y; Wang YZ; Shen Y; Chen G; Peng W; Fang Z; Xia B; Chen X; Song K; Wang Y; Zou D; Wang YC; Han Y; Feng X; Yuan J; Guo S; Meng X; Feng C; Chen Y; Yang J; Fan J; Wang J; Ai J; Ma D; Sun C
Lancet Oncol; 2024 Jan; 25(1):76-85. PubMed ID: 38048802
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant chemotherapy with weekly cisplatin and paclitaxel followed by chemoradiation for locally advanced cervical cancer.
Li J; Li Y; Wang H; Shen L; Wang Q; Shao S; Shen Y; Xu H; Liu H; Cai R; Feng W
BMC Cancer; 2023 Jan; 23(1):51. PubMed ID: 36641433
[TBL] [Abstract][Full Text] [Related]
4. Comparison of outcomes and side effects for neoadjuvant chemotherapy with weekly cisplatin and paclitaxel followed by chemoradiation vs. chemoradiation alone in stage IIB-IVA cervical cancer: study protocol for a randomized controlled trial.
Li J; Liu H; Li Y; Li J; Shen L; Long W; Yang C; Xu H; Xi W; Cai R; Feng W
Trials; 2022 Jan; 23(1):29. PubMed ID: 35012634
[TBL] [Abstract][Full Text] [Related]
5. Study protocol of short-course radiotherapy combined with CAPOX and PD-1 inhibitor for locally advanced colon cancer: a randomised, prospective, multicentre, phase II trial (TORCH-C).
Zhang H; Li Y; Xia F; Sun Y; Shen L; Wan J; Chen Y; Wang Y; Zhou M; Wu R; Zhou S; Wang Y; Liu F; Cai S; Zhang Z
BMJ Open; 2024 Feb; 14(2):e079442. PubMed ID: 38309748
[TBL] [Abstract][Full Text] [Related]
6. Induction PD-1 inhibitor toripalimab plus chemotherapy followed by concurrent chemoradiotherapy and consolidation toripalimab for bulky locally advanced non-small-cell lung cancer: protocol for a randomized phase II trial (InTRist study).
Wang Y; Deng L; Wang J; Zhang T; Wang W; Wang X; Liu W; Wu Y; Lv J; Feng Q; Zhou Z; Wang J; Wang L; Wang Z; Bi N
Front Immunol; 2023; 14():1341584. PubMed ID: 38288117
[TBL] [Abstract][Full Text] [Related]
7. Short-course radiotherapy combined with chemotherapy and PD-1 inhibitor in low-lying early rectal cancer: study protocol for a single-arm, multicentre, prospective, phase II trial (TORCH-E).
Chen Y; Wang Y; Zhang H; Wan J; Shen L; Wang Y; Zhou M; Wu R; Yang W; Zhou S; Cai S; Li X; Zhang Z; Xia F
BMJ Open; 2023 Oct; 13(10):e076048. PubMed ID: 37802608
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant Arterial Embolization Chemotherapy Combined PD-1 Inhibitor for Locally Advanced Rectal Cancer (NECI Study): a protocol for a phase II study.
Fan Y; Zhu X; Xu C; Ding C; Hu J; Hong Q; Wang J
BMJ Open; 2023 Mar; 13(3):e069401. PubMed ID: 36914193
[TBL] [Abstract][Full Text] [Related]
9. A prospective trial to evaluate the clinical efficacy and safety of neoadjuvant chemotherapy with arsenic trioxide and carboplatin in locally advanced cervical cancer: a study protocol for randomized controlled clinical.
He ZY; Li HY; Yan J; Li SJ; Li DC; Liang ZZ
Trials; 2022 Jul; 23(1):556. PubMed ID: 35804452
[TBL] [Abstract][Full Text] [Related]
10. Analysis of short-term efficacy as defined by RECIST and pathological response of neoadjuvant chemotherapy comprised paclitaxel and cisplatin followed by radical surgery in patients with locally advanced cervical cancer: A prospective observational study.
He Y; Zhao Q; Geng YN; Yang SL; Li XM; Finas D; Yin CH; Wu YM
Medicine (Baltimore); 2018 Jun; 97(22):e10913. PubMed ID: 29851821
[TBL] [Abstract][Full Text] [Related]
11. Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial.
Lee JB; Kim HS; Jung I; Shin SJ; Beom SH; Chang JS; Koom WS; Kim TI; Hur H; Min BS; Kim NK; Park S; Jeong SY; Baek JH; Kim SH; Lim JS; Lee KY; Ahn JB
Trials; 2020 Apr; 21(1):320. PubMed ID: 32264919
[TBL] [Abstract][Full Text] [Related]
12. Camrelizumab in combination with chemotherapy versus concurrent chemoradiotherapy for the conversion of locally advanced unresectable oesophageal squamous carcinoma: protocol for a two-arm, open-label phase II trial.
Chen M; Huang Y; Zhang S; Zheng Y; Zeng T; Chen C; Zheng B
BMJ Open; 2024 Feb; 14(2):e075421. PubMed ID: 38418234
[TBL] [Abstract][Full Text] [Related]
13. Toripalimab combined with concurrent platinum-based Chemoradiotherapy in patients with locally advanced cervical Cancer: an open-label, single-arm, phase II trial.
Chen J; Li C; Cao Y; Zhu L; Zhang B; You J; Hou H; Wang J; Yuan Z
BMC Cancer; 2022 Jul; 22(1):793. PubMed ID: 35854236
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant chemotherapy for patients with international federation of gynecology and obstetrics stages IB3 and IIA2 cervical cancer: a multicenter prospective trial.
Hu Y; Han Y; Shen Y; Chen J; Chen Y; Chen Y; Tang J; Xue M; Hong L; Cheng W; Wang D; Liang Z; Wang Y; Zhang Q; Xing H; Zhang Y; Yi C; Yu Z; Chen Y; Cui M; Ma C; Yang H; Li R; Long P; Zhao Y; Qu P; Tao G; Yang L; Wu S; Liu Z; Yang P; Lv W; Xie X; Ma D; Wang H; Li K
BMC Cancer; 2022 Dec; 22(1):1270. PubMed ID: 36471257
[TBL] [Abstract][Full Text] [Related]
15. Radiation therapy before radical cystectomy combined with immunotherapy in locally advanced bladder cancer - study protocol of a prospective, single arm, multicenter phase II trial (RACE IT).
Schmid SC; Koll FJ; Rödel C; Maisch P; Sauter A; Beckert F; Seitz A; Kübler H; Flentje M; Chun F; Combs SE; Schiller K; Gschwend JE; Retz M
BMC Cancer; 2020 Jan; 20(1):8. PubMed ID: 31900121
[TBL] [Abstract][Full Text] [Related]
16. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.
Kokka F; Bryant A; Brockbank E; Powell M; Oram D
Cochrane Database Syst Rev; 2015 Apr; (4):CD010260. PubMed ID: 25847525
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant chemotherapy followed by radical surgery reduces radiation therapy in patients with stage IB2 to IIA2 cervical cancer.
Huang Y; Chen L; Cai J; Yang L; Sun S; Zhao J; Xiong Z; Wang Z
World J Surg Oncol; 2022 Aug; 20(1):264. PubMed ID: 35996118
[TBL] [Abstract][Full Text] [Related]
18. Single-arm, phase II study of intra-arterial chemotherapy plus total neoadjuvant therapy to optimise complete response in distal rectal cancer: a study protocol.
Huang W; Huang P; Guo H; Huang Z; Wei M; Guo J; Lin C; Li Y; Luo B; Lin J; Wang L
BMJ Open; 2023 Oct; 13(10):e075023. PubMed ID: 37798027
[TBL] [Abstract][Full Text] [Related]
19. Three-arm phase II trial comparing camrelizumab plus chemotherapy versus camrelizumab plus chemoradiation versus chemoradiation as preoperative treatment for locally advanced esophageal squamous cell carcinoma (NICE-2 Study).
Yang Y; Zhu L; Cheng Y; Liu Z; Cai X; Shao J; Zhang M; Liu J; Sun Y; Li Y; Yi J; Yu B; Jiang H; Chen H; Yang H; Tan L; Li Z
BMC Cancer; 2022 May; 22(1):506. PubMed ID: 35524205
[TBL] [Abstract][Full Text] [Related]
20. Long-course chemoradiation plus concurrent/sequential PD-1 blockade as neoadjuvant treatment for MMR-status-unscreened locally advanced rectal cancer: protocol of a multicentre, phase 2, randomised controlled trial (the POLAR-STAR trial).
Pang K; Yang Y; Tian D; Zeng N; Cao S; Ling S; Gao J; Zhao P; Wang H; Kong Y; Zhang J; Chen G; Deng W; Bai Z; Jin L; Wu G; Zhu D; Wang Y; Zhou J; Wu B; Lin G; Xiao Y; Gao Z; Ye Y; Wang X; Li A; Han J; Yao H; Yang Y; Zhang Z
BMJ Open; 2023 Sep; 13(9):e069499. PubMed ID: 37699634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
